Bull Case

Revenue growth re-accelerates as project execution and customer conversion improve, lifting scale versus smaller peers that remain more dependent on lumpy order timing.

Gross margin expands from deeply negative levels as mix shifts toward higher-value work and fixed-cost absorption improves, narrowing the gap with better-capitalized peers.

Operating losses compress materially if overhead discipline and utilization improve, allowing EBITDA to move toward breakeven faster than peers with weaker cost control.

Balance-sheet pressure remains manageable because net debt is low, giving SPPL more operating flexibility than highly levered peers during a recovery phase.

Base Case

Revenue remains uneven but stabilizes as existing demand supports modest volume recovery, leaving SPPL behind steadier peers with more recurring end-market exposure.

Margins stay negative because pricing and utilization gains only partly offset fixed costs, keeping operating performance weaker than profitable peers.

Cash burn persists at a reduced pace, and limited interest coverage constrains financial flexibility relative to peers with positive earnings and stronger coverage.

Net debt stays contained, but weak profitability prevents leverage from becoming a meaningful advantage versus peers with cleaner earnings power.

Bear Case

Demand softens or project delays persist, causing revenue to decline further and widening the gap versus peers with more diversified order books.

Negative margins deepen if under-absorption and pricing pressure continue, pushing operating losses materially below peer levels.

Weak earnings and negative interest coverage increase refinancing or dilution risk, especially versus peers that can fund growth internally.

Low leverage offers only limited protection if cash burn accelerates, because liquidity stress would still dominate the operating outlook.

Overall Score

SPPL’s forward path is most likely a low-growth, loss-making recovery with limited balance-sheet support, while upside depends on margin normalization that remains unproven versus peers.